Changeflow GovPing Pharma & Drug Safety Vital Pulp Therapy Using Bioactive Composites
Routine Notice Added Final

Vital Pulp Therapy Using Bioactive Composites

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published patent application US20260090960A1 by Imam Abdulrahman Bin Faisal University for a method of vital pulp therapy using a bioactive capping material. The invention comprises a mixture of glass ionomer cement (GIC) and potassium nitrate (KNO3) in 1-10 wt.% concentration with a solvent. The application was filed September 30, 2024.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260090960A1 disclosing a method of vital pulp therapy using a bioactive capping material. The method involves drilling into a decayed tooth pulp, excavating infected pulp, and covering healthy pulp with a bioactive capping material prepared by mixing glass ionomer cement (GIC) and potassium nitrate (KNO3) at 1-10 wt.% with a solvent, followed by curing. The application lists four inventors: Mohammed ALGHARNI, Omar OMAR, Fatimah DAHLAWI, and Jehan ALHUMAID.

Patent applications do not create immediate compliance obligations for industry. Healthcare providers and medical device manufacturers should monitor patent prosecution progress to assess potential licensing requirements. Entities developing similar dental capping materials should conduct freedom-to-operate analyses before commercialization, as the patent, if granted, would provide exclusive rights to this specific composition and method.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD OF VITAL PULP THERAPY USING BIOACTIVE COMPOSITES

Application US20260090960A1 Kind: A1 Apr 02, 2026

Assignee

IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY

Inventors

Mohammed ALGHARNI, Omar OMAR, Fatimah DAHLAWI, Jehan ALHUMAID

Abstract

A method of vital pulp therapy with a bioactive capping material. The method includes drilling into a pulp of a tooth having decay to form a hole, then excavating infected pulp from the hole. The bioactive capping material is prepared by mixing glass ionomer cement (GIC) and potassium nitrate (KNO3) with a solvent. The method further includes covering healthy pulp in the tooth with the bioactive capping material and curing the bioactive capping material to form a cured capping material. The bioactive capping material includes KNO3 in an amount of 1 to 10 percent by weight (wt. %) based on the weight of the capping material.

CPC Classifications

A61K 6/849 A61K 6/84 A61K 31/739

Filing Date

2024-09-30

Application No.

18901829

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260090960A1 / Application No. 18901829

Who this affects

Applies to
Healthcare providers Medical device makers Patients
Industry sector
6211 Healthcare Providers 3345 Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!